Left Menu
Development News Edition

USFDA completes inspection of JB Chemicals' Panoli facility without any observations

PTI | New Delhi | Updated: 03-07-2019 12:57 IST | Created: 03-07-2019 12:52 IST
USFDA completes inspection of JB Chemicals' Panoli facility without any observations
Image Credit: Flickr

JB Chemicals & Pharmaceuticals Wednesday said the US health regulator has concluded inspection of its manufacturing facility at Panoli in Gujarat without any observations. The US Food and Drug Administration (USFDA) has concluded inspection of company's newly set-up and commissioned solid oral dosage forms formulations manufacturing facility at Panoli, Gujarat, JB Chemicals & Pharmaceuticals said in a BSE filing.

"At the end of inspection, no objectionable observations were found and hence no form 483 was issued," it stated. The said inspection was carried out from June 24-28, 2019, the company said.

A Form 483, is issued by the USFDA to notify a company's management of any objectionable condition at its manufacturing facility. The form is issued after completing the inspection. JB Chemicals & Pharmaceuticals said this facility has capacity of two billion tablets per annum, which is expandable to nine billion tablets per annum.

The company said new facility will augment its manufacturing capacity for regulated markets like the USA and the EU, as and when the product approvals are received. Shares of JB Chemicals & Pharmaceuticals were trading 1.83 per cent lower at Rs 365.75 apiece on the BSE.



3D printing and the future of manufacturing post COVID-19

The on-demand, customizable, and localized manufacturing of product components facilitated by 3D printing has the potential to redefine manufacturing but there are certain technical, mechanical, and legal limitations that, unless ...

How UK’s 'best prepared' healthcare system failed to gauge COVID-19

The UK is proud of their public health system and its unlike any other country as around 90 percent of British public supports the founding principles of National Health Service. But without accurate data being available to stakeholders in ...

Poor on IHR capacity progress in 2019, WHO says Cambodia tops COVID-19 response

Despite being in proximity to Hubei, the original epicenter of COVID-19 pandemic, Cambodia has reported just 226 confirmed cases and zero deaths. After seeing the data, WHO appreciated Cambodias healthcare information system but experts dou...

Loopholes in Healthcare Information System may have failed Singapore COVID-19 model

In the initial days of the COVID-19 outbreak, Singapore was in the limelight for its effective healthcare system and pandemic response plan. However, Singapore has now joined the list of the worst-hit nations and the situation is even worse...


Latest News

Palghar lynching: SC asks Maha govt to file status report on inquiry against policemen

The Supreme Court Thursday asked the Maharashtra government to apprise it of the inquiry and action taken against the errant police personnel in the alleged lynching of three people, including two seers, in Palghar district in April. A benc...

75 years after the bomb, Hiroshima still chooses ‘reconciliation and hope’

Seventy-five years ago, a single nuclear weapon visited unspeakable death and destruction upon this city, he said in his video message. The effects linger to this day.However, he noted that Hiroshima and its people have chosen not to be cha...

London stocks slide as BoE sees slower recovery; Glencore slumps

London-listed shares dove on Thursday as the Bank of England forecast a slower-than-expected rebound from the COVID-19 pandemic, while Glencore tumbled after scrapping its dividend to pay down debt. The miner fell 4.6 as it also booked a 3....

Anika misses out match play spot at US Women's Amateur Championship

Anika Varma bounced back strongly in the last six holes of her second round but missed out on qualifying for the match play of the US Womens Amateur Championship, falling short by just one shot. The second round, delayed to Wednesday due...

Give Feedback